Shreya Kar

683 total citations
8 papers, 500 citations indexed

About

Shreya Kar is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shreya Kar has authored 8 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Shreya Kar's work include Breast Cancer Treatment Studies (2 papers), Immune cells in cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). Shreya Kar is often cited by papers focused on Breast Cancer Treatment Studies (2 papers), Immune cells in cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). Shreya Kar collaborates with scholars based in Singapore, Australia and United States. Shreya Kar's co-authors include Alan Prem Kumar, Frank Arfuso, Gautam Sethi, Lina H. K. Lim, Arun Dharmarajan, Vinay Tergaonkar, Chung Yeng Looi, Madhu M. Kanchi, Anupam Bishayee and Mohammad Rais Mustafa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Shreya Kar

8 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shreya Kar Singapore	6	290	138	101	98	46	8	500
Guoguo Jin China	14	350 1.2×	142 1.0×	131 1.3×	74 0.8×	68 1.5×	25	643
Vinod Balachandran India	12	315 1.1×	130 0.9×	62 0.6×	66 0.7×	44 1.0×	14	598
Xingkai Liu China	15	366 1.3×	116 0.8×	97 1.0×	73 0.7×	72 1.6×	39	692
Yunong Li China	9	248 0.9×	79 0.6×	100 1.0×	104 1.1×	33 0.7×	14	521
MyongHak Ri China	11	230 0.8×	108 0.8×	89 0.9×	77 0.8×	58 1.3×	12	447
Chunpu Zou China	12	258 0.9×	86 0.6×	80 0.8×	80 0.8×	53 1.2×	24	458
Sima Mansoori Derakhshan Iran	5	325 1.1×	69 0.5×	103 1.0×	64 0.7×	49 1.1×	22	533
Deok Yong Sim South Korea	15	332 1.1×	100 0.7×	123 1.2×	57 0.6×	38 0.8×	39	497
Jianyang Hu China	11	354 1.2×	92 0.7×	100 1.0×	51 0.5×	46 1.0×	16	511
Clarissa Esmeralda Halim Singapore	7	349 1.2×	155 1.1×	109 1.1×	60 0.6×	43 0.9×	9	640

Countries citing papers authored by Shreya Kar

Since Specialization

Citations

This map shows the geographic impact of Shreya Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shreya Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shreya Kar more than expected).

Fields of papers citing papers by Shreya Kar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shreya Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shreya Kar. The network helps show where Shreya Kar may publish in the future.

Co-authorship network of co-authors of Shreya Kar

This figure shows the co-authorship network connecting the top 25 collaborators of Shreya Kar. A scholar is included among the top collaborators of Shreya Kar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shreya Kar. Shreya Kar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Cui, Jianzhou, Karishma Sachaphibulkij, Shreya Kar, et al.. (2023). Macrophage IL-1β contributes to tumorigenesis through paracrine AIM2 inflammasome activation in the tumor microenvironment. Frontiers in Immunology. 14. 1211730–1211730. 8 indexed citations

Thakkar, Dipti, Bhushan Dharmadhikari, Siyu Guan, et al.. (2022). Rationally targeted anti-VISTA antibody that blockades the C-C’ loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner. Journal for ImmunoTherapy of Cancer. 10(2). e003382–e003382. 46 indexed citations

Thakkar, Dipti, Shreya Kar, Namita Gandhi, et al.. (2021). Abstract P197: An anti-HER3 antibody, HMBD-001, that uniquely binds to and blocks the HER3 heterodimerization interface, shows superior tumor growth inhibition in biomarker-defined preclinical cancer models including NRG1-fusion driven cancers. Molecular Cancer Therapeutics. 20(12_Supplement). P197–P197. 5 indexed citations

Kar, Shreya, et al.. (2020). Primary Ewing's sarcoma/Primitive neuroectodermal tumour of the kidney: Report of four cases from a tertiary care centre.. SHILAP Revista de lepidopterología. 3. 100043–100043. 2 indexed citations

Moraes, Leonardo A., Shreya Kar, Sok Lin Foo, et al.. (2017). Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment. Scientific Reports. 7(1). 17925–17925. 85 indexed citations

Wang, Chao, Shreya Kar, Xianning Lai, et al.. (2017). Triple negative breast cancer in Asia: An insider’s view. Cancer Treatment Reviews. 62. 29–38. 150 indexed citations

Kumavath, Ranjith, Pratap Devarapalli, Sandeep Tiwari, et al.. (2016). Novel aromatase inhibitors selection using induced fit docking and extra precision methods: Potential clinical use in ER-alpha-positive breast cancer. Bioinformation. 12(6). 324–331. 7 indexed citations

Shanmugam, Muthu K., Jong Hyun Lee, Madhu M. Kanchi, et al.. (2016). Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Seminars in Cancer Biology. 40-41. 35–47. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact